Production of medicinal products on the basis of herbal raw materials historically has been the visiting card of BCPP. Considering the great interest of modern market to such products BCPP aims for enlarging own product portfolio with original products of herbal origin:
Herbal anti-viral medication developed under the original technology for local administration in case of treatment the infections of skin and mucous membranes caused by Herpes simplex virus of I and II types (primary and secondary) is now at the stage of clinical investigation. It is supposed that due to the herbal origin of active ingredient the product will have better safety profile.
Nonsteroidal anti-inflammatory and antirheumatic products
The company conducts the development of new medicinal product being the combination of known NSAID preparation with flavonoid in order to enlarge the potential possibilities of “classic” NSAID preparation and decreasing the side effects in gastro-intestinal tract.
The enterprise is prepared for the first phase of clinical studies of new medicinal product for treatment of type 2 diabetes. Active ingredient is the new molecule belonging to the class of almost non-toxic agents and is manufactured by our plant. It is supposed that medicinal product will have the similar efficacy as widely used preparations together in considerably lower therapeutic dose of active ingredient.
Products for varicose veins
Now the clinical studies of combined anti-thrombotic anti-edemic medicinal product with anti-inflammatory effect for topical administration for prevention and treatment of varix dilatation are starting. It is supposed that the advantage over the monocomponent preparations will be assured due to complex action of components on different segments of microcirculatory disorders in case of varix dilatation.